GlassScriptPhysician profile
Jin Hwang
NPI 1073701975
$13,054.85
in general payments reported to CMS, 2019-2025
19 companies · $1,535 in 2025
The $1,535 reported for 2025 was more than what 97% of Dentist providers received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $307 · 2020: $150 · 2021: $1,108 · 2022: $6,544 · 2023: $2,742 · 2024: $668 · 2025: $1,535.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,277 · Gift: $1,355 · Honoraria: $526 · Entertainment: $500 · Education: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,276.99 |
| Gift | $1,355.00 |
| Honoraria | $526.28 |
| Entertainment | $500.00 |
| Education | $287.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| A-Dec, INC. | $6,365.00 | 2022-2025 | |
| Dentsply Sirona INC | $1,781.97 | 2021-2024 | Smartlite Focus, Cerec, Nupro |
| Benco Dental Supply Co. | $1,661.21 | 2021-2025 | |
| Voco America INC. | $940.25 | 2019-2023 | Futurabond U, Admira Fusion X-Tra, Meron Plus Qm |
| Kerr Corporation | $556.31 | 2021-2023 | Endodontics |
| Align Technology, INC. | $314.52 | 2019-2025 | Invisalign |
| Zimmer Biomet Holdings, INC. | $286.89 | 2019-2021 | |
| Gc America INC. | $236.16 | 2023-2025 | G-Premio Bond, Gc Initial, Mipaste One |
| Envista Holdings Corporation | $160.00 | 2024 | Optibond Solo Plus, Harmonize, Maxcem Elite |
| Kulzer, LLC | $133.12 | 2021-2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $124.45 | 2025 | Arestin |
| Henry Schein, INC. | $121.15 | 2019-2021 | |
| Nobel Biocare USA | $109.26 | 2023 | Nobelactive |
| Straumann USA LLC | $91.20 | 2025 | |
| Midmark Corporation | $64.13 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Planmeca USA, INC. | $47.87 | 2019 | |
| Solventum Corporation | $26.00 | 2024 | 3m Relyx, 3m Filtek, Relyx Unicem 2 Automix |
| 3m Company | $18.57 | 2019 | |
| Dexcel Pharma Technologies LTD. | $16.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jin Hwang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.